This week, 4 Life Sciences Tools & Services stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Mettler-Toledo International Inc.’s (MTD) ratings are up from a B last week to a A. Mettler-Toledo International Inc. supplies precision instruments and services and is a provider of weighing instruments for use in laboratory, industrial and food retailing applications. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of MTD stock.
PerkinElmer, Inc. (PKI) earns a B this week, jumping up from last week’s grade of C. PerkinElmer, Inc. provides technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services market. The company also gets A’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of PKI stock.
This is a strong week for Luminex Corp (LMNX). The company’s rating climbs to B from the previous week’s C. Luminex Corp develops, manufactures and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The company also gets A’s in earnings growth. For more information, get Portfolio Grader’s complete analysis of LMNX stock.
NeoGenomics, Inc. (NEO) boosts its rating from a C to a B this week. NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company also gets A’s in sales growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of NEO stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
